Abstract
The combination of targeted transport and improvement of the release profile of the active pharmaceutical ingredient (API) is a current trend in the development of oral medicinal products (MP). A well-known way to implement this concept is to obtain floating gastroretentive delivery systems that provide a long stay of the dosage form (DF) on the surface of the stomach contents. The nomenclature of excipients (Es) of a polymeric nature used in the technology of obtaining floating drug delivery systems (FDDS) is discussed. Based on the data presented in research papers, the most widely used groups of polymers, their properties, and their purpose in various technological approaches to achieving buoyancy have been determined. In addition, ways to modify the release of APIs in these systems and the Es used for this are described. The current trends in the use of polymers in the technology of floating dosage forms (FDF) and generalized conclusions about the prospects of this direction are outlined.
Funder
RUDN University Strategic Academic Leadership Program
Reference151 articles.
1. Tripathi, J., Thapa, P., Maharjan, R., and Jeong, S.H. (2019). Current State and Future Perspectives on Gastroretentive Drug Delivery Systems. Pharmaceutics, 11.
2. Vrettos, N.-N., Roberts, C.J., and Zhu, Z. (2021). Gastroretentive Technologies in Tandem with Controlled-Release Strategies: A Potent Answer to Oral Drug Bioavailability and Patient Compliance Implications. Pharmaceutics, 13.
3. Overview on gastroretentive drug delivery systems for improving drug bioavailability;Lopes;Int. J. Pharm.,2016
4. Approaches to Achieve an Oral Controlled Release Drug Delivery System Using Polymers: A Recent Review;Arafat;Int. J. Pharm. Pharm. Sci.,2015
5. A Review on Floating Multi-particulate Drug Delivery System;Pund;Res. J. Pharm. Technol.,2021
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献